1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

Xiaozhe Li,Wenming Chen,Yin Wu,Jian-yong Li,Lijuan Chen,Baijun Fang,Ying Feng,Junru Liu,Meilan Chen,Jingli Gu,Beihui Huang,Juan Li

1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

2019

Xiaozhe Li
Wenming Chen
Yin Wu
Jian-yong Li
Lijuan Chen
Baijun Fang
Ying Feng
Junru Liu
Meilan Chen
Jingli Gu
Beihui Huang
Juan Li

Background. The prognostic value of 1q21 gain in newly diagnosed multiple myeloma (NDMM) remains controversial. Our aim was to investigate the prognostic value of 1q21 gain in a Chinese population.

Keywords:

Internal medicine
Oncology
High risk factors
Pathology
Medicine
Multiple myeloma
Multivariate analysis
Lactate dehydrogenase
Copy-number variation
Autologous stem-cell transplantation
newly diagnosed
Bortezomib

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations